G49108TO
| Organisms | Evidence |
|---|---|
| Mus musculus (house mouse) | |
| Rattus norvegicus (Norway rat) | |
| Homo sapiens (human) | |
| Drosophila melanogaster (fruit fly) | |
| Streptococcus pneumoniae |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B3GALT1 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B4GALNT3 | UDP-GalNAc |
|
R |
|
R | |
| B3GALNT2 | UDP-GalNAc |
|
R |
|
R | |
| B4GALNT4 | UDP-GalNAc |
|
R |
|
R | |
| B4GALT1 | UDP-Glc |
|
R |
|
R |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
| B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
| B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
| B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
| UniProt ID | Protein Name | Reference | Source |
|---|---|---|---|
| U3KPZ7 | RNA-binding protein 27 | ||
| V6CIU7 | choline-phosphate cytidylyltransferase | ||
| V6CKC3 | C2H2-type domain-containing protein | ||
| V9GYH0 | Homeobox domain-containing protein (Fragment) |
| Pathway Name | Organism |
|---|---|
| Antimicrobial peptides | Xenopus tropicalis |
| Antimicrobial peptides | Rattus norvegicus |
| Antimicrobial peptides | Danio rerio |
| Antimicrobial peptides | Bos taurus |
| Antimicrobial peptides | Canis familiaris |
| Antimicrobial peptides | Sus scrofa |
| Antimicrobial peptides | Dictyostelium discoideum |
| Antimicrobial peptides | Mus musculus |
| Antimicrobial peptides | Drosophila melanogaster |
| Antimicrobial peptides | Homo sapiens |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 37655824 | N-Acetylglucosamine and its dimer ameliorate inflammation in murine colitis by strengthening the gut barrier function | Choi SI | 2023 Sep 19 |
|
| 37723174 | Structure of human drug transporters OATP1B1 and OATP1B3 | Ciută AD | 2023 Sep 18 |
|
| 37704615 | Broadly neutralizing antibodies derived from the earliest COVID-19 convalescents protect mice from SARS-CoV-2 variants challenge | Liu Q | 2023 Sep 14 |
|
| 37705084 | N-acetylglucosamine inhibits inflammation and neurodegeneration markers in multiple sclerosis: a mechanistic trial | Sy M | 2023 Sep 13 |
|
| 37704610 | De novo design of highly selective miniprotein inhibitors of integrins αvβ6 and αvβ8 | Roy A | 2023 Sep 13 |
|
| 37684251 | Structural insight into the substrate recognition and transport mechanism of amino acid transporter complex ACE2-B0AT1 and ACE2-SIT1 | Li Y | 2023 Sep 08 |
|
| 37675979 | Biophysical characterization of PVR family interactions and therapeutic antibody recognition to TIGIT | Diong SJ | 2023 Sep 07 |
|
| 37619561 | CryoEM structure of a therapeutic antibody (favezelimab) bound to human LAG3 determined using a bivalent Fab as fiducial marker | Mishra AK | 2023 Sep 06 |
|
| 37674011 | Cryo-EM structures of human organic anion transporting polypeptide OATP1B1 | Shan Z | 2023 Sep 06 |
|
| 37975141 | Melatonin and probiotic administration ameliorated hyperglycaemia, oxidative stress, and enhanced cytoprotective effect on beta-cells of diabetic rats | Aluwong T | 2023 Sep 05 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.3.0
Last updated: August 4, 2025